搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
EurekAlert!
4 天
Borrowing nature’s blueprint: How scientists replicated bone marrow
Penn researchers have developed a platform that emulates human bone marrow’s native environment. This breakthrough addresses ...
来自MSN
2 天
Breakthrough model simulates human bone marrow function in the lab
Hidden within our bones, marrow sustains life by producing billions of blood cells daily, from oxygen-carrying red cells to ...
3 天
on MSN
NHS to offer 'groundbreaking' sickle cell gene therapy
The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...
drugtargetreview.com
4 天
Cilta-cel: A new era in multiple myeloma treatment
New cell therapy, Cilta-cel, shows promise in the treatment of multiple myeloma, providing a personalised approach with the ...
Science Media Centre
3 天
expert reaction to NICE final draft guidance on exagamglogene autotemcel (exa-cel) for ...
January 31, 2025 expert reaction to NICE final draft guidance on exagamglogene autotemcel (exa-cel) for severe sickle cell disease . Scientists comment on final draft guidance fro ...
2 天
on MSN
UK health system to offer cutting-edge gene therapy for sickle cell disease
The therapy involves taking stem cells out of a patient's bone marrow and editing a gene in the cells in a laboratory and ...
PMLiVE
2 天
NICE approves Vertex’s Casgevy one-time gene therapy for sickle cell disease
The National Institute for Health and Care Excellence (NICE) has approved Vertex Pharmaceuticals’ Casgevy (exagamglogene ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈